Hims & Hers Health (HIMS) Current Deferred Revenue (2020 - 2026)

Hims & Hers Health has disclosed Current Deferred Revenue across 7 years of filings, most recently posting $141.4 million for Q2 2026.

• In Q2 2026, Current Deferred Revenue rose 43.67% year-over-year to $141.4 million; the TTM figure through Jun 2026 stood at $141.4 million (up 43.67% YoY), while the FY2025 annual figure was $127.2 million, up 68.92% from the prior year.
• Current Deferred Revenue came in at $141.4 million for Q2 2026 at Hims & Hers Health, down from $165.1 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $165.1 million in Q1 2026 to a low of $1.1 million in Q1 2022.
• Average Current Deferred Revenue over 5 years is $51.5 million, with a median of $17.4 million recorded in 2024.
• Year-over-year, Current Deferred Revenue tumbled 53.83% in 2022 and soared 919.92% in 2024.
• Over 5 years, Current Deferred Revenue stood at $1.5 million in 2022, then soared by 425.34% to $7.7 million in 2023, then surged by 873.75% to $75.3 million in 2024, then soared by 68.92% to $127.2 million in 2025, then advanced by 11.16% to $141.4 million in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $141.4 million in Q2 2026, $165.1 million in Q1 2026, and $127.2 million in Q4 2025.